The Quantum Group Files Four Additional Patents

Company Expands IP Portfolio to Nine Filings, with Additional Applications
Expected

WELLINGTON, Fla., April 17 /PRNewswire-FirstCall/ -- The Quantum Group,
Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (www.QuantumMD.com) announced today that it
has filed four additional provisional business process patents with the United
States Patent and Trademark Office, adding to the five applications filed and
announced in January 2008.
Collectively, these nine patents are considered to be strategic building
blocks to the dynamic, multidimensional architecture the Company is
constructing to address the communication obstacles the Company believes
inherent in the coordination of patient care. Quantum deems that these current
obstacles are due to the inability of patients to fully understand their
current health analysis and the possible risk factors that affect them. The
technology and IP behind the patents are the core components for building a
technology platform that will allow doctors to use the latest practice
automation to more effectively treat patients and promote wellness.
Traditionally, the focus of the medical industry has been on reacting to the
immediate, episodic events of a patient, rather than taking a proactive,
preventative approach to wellness. A broader predictive medical logistics
platform is expected to enrich the science of healthcare by driving
unprecedented knowledge through information management, data mining and
predictive modeling of trends and causes in a new, unexplored way.
Pete Martinez, Senior Vice President and Chief Technology & Innovations
Officer of The Quantum Group, has led the team developing the technology and
processes behind these patents. Martinez stated, "These patents represent the
foundation of a platform that has the potential to modernize healthcare by
simplifying the underlying processes and enhancing the overall quality and
cost of care. The Quantum Group provides the fertile ground necessary to
implement an automated system that has the power to touch the critical mass of
healthcare providers, patients and multiple top tier payers under management."
Martinez added, "We expect to announce the filing of several more patent
applications in the coming months that will contribute further to the
development and enhancement of this well founded platform."
Noel J. Guillama, President and CEO of The Quantum Group, stated, "The
concept of this system, driven by innovative and dynamic processes, continues
to be a vital component of the foundation of this Company. We chose to change
the status quo. It is exciting to see it coming to the forefront and we
believe the results and impact will be dramatic for our Company, our partners
and most importantly our patients."
About The Quantum Group, Inc.
The Quantum Group provides business process solutions, service chain
management, strategic consulting and leading edge technology innovations to
the healthcare industry.
Through our dynamic patient-centric architecture, we empower the
communication that is critical for the coordination of care and take aim at
the $600 billion inefficiency gap in the United States healthcare industry. We
are guided by a mission to develop efficiencies, improve the quality of
patient care and achieve cost reductions for the nation's largest and fastest
growing industry.
We have developed leading-edge technology with the creation and deployment
of a series of innovative patent-pending initiatives. Through 1,900+
healthcare providers and multiple insurance company relationships under
management, we are positioned to be a catalyst for change to the Florida
healthcare industry.
Certain statements contained in this news release, which are not based on
historical facts, are forward-looking statements as the term is defined in the
Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K
filings (and amendments thereto) that may cause actual results to materially
differ from projections. Forward-looking statements can be identified by the
use of words such as "expects," "plans," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates" and other words of similar
meaning. These statements are subject to risks and uncertainties that cannot
be predicted or quantified and, consequently, actual results may differ
materially from those expressed or implied by these forward-looking
statements. Such risk factors include, without limitation, the ability of the
Company to properly execute its business model, to raise substantial and
immediate additional capital to implement its business model, to attract and
retain executive, management and operational personnel, to negotiate favorable
current debt and future capital raises, to negotiate favorable agreements with
a diversified provider base and to continue to supply the services needed by
its HMO clients as well physician clients. The Company does not undertake any
obligation to publicly update any forward-looking statements. There can be no
assurance that the provisional patents discussed in this press release will be
granted by the US Patent and Trademark Office, or, if they are granted, they
will not be challenged by third parties, or if not that we will be able to
effectively use or commercialize such patents and/or we may not have the
resources to deploy such technology. As a result, investors should not place
undue reliance on these forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT:
BPC Financial Marketing
John Baldissera
800.368.1217
or
PR Financial Marketing
Jim Blackman
713-256-0369
jim@prfmonline.com
or
The Quantum Group, Inc.
Danielle Amodio
561.798.9800

SOURCE The Quantum Group, Inc.

Danielle Amodio of The Quantum Group, Inc., +1-561-798-9800; or John
Baldissera of BPC Financial Marketing, +1-800-368-1217; or Jim Blackman of PR
Financial Marketing, +1-713-256-0369, jim@prfmonline.com